FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201743025> ?p ?o ?g. }

• W3201743025 abstract "Objective: Currently, immune checkpoint inhibitors (ICIs) play a central role in the treatment of lung cancer. However, ICI re-administration is still uncommon, and its utility should be evaluated as early as possible. Patients and Methods: Twenty-five patients who received ICIs twice or more in any of the drug treatment lines for advanced/relapsed non-small cell lung cancer were included. OS, PFS, ORR, and DCR were examined, and factors such as age, sex, histopathological type, PD-L1 expression, whether radical surgery was performed, driver gene mutations, and immune-related adverse events (irAEs), were evaluated for their relevance and as prognostic factors. Results: Of the 25 patients, 17 were men and 8 were women, with an average age of 68 ± 8.4 (range, 48-85 years), and histology was non-squamous cell carcinoma/squamous cell carcinoma in 19/6 cases. One driver gene mutation positive case was included. PD-L1 TPS was ≥50%/1-49%/0-1%/ unknown in 7/8/5/5 cases. The first ICI administered was pembrolizumab/nivolumab/atezolizumab in 5/13/7 cases. The median number of courses was 9 (range, 1-52) months, and the median PFS was 9 (95% CI, 6.0-12.0) months. Cytotoxic chemotherapy or radiation therapy was administered to 6 patients during the interval up to re-administration. The second ICI administered was pembrolizumab/nivolumab/atezolizumab in 5/8/12 cases, and all patients received antibody drugs different from those given as the first ICI. The median number of courses was 5 (range, 1-24), and the median PFS was 3 months (95% CI, 1.0-5.0) months. In 5 of the 6 patients (24%) who achieved PFS of 6 months or longer after re-administration, the order of administration was anti-PD-1 antibody to anti-PD-L1 antibody. Conclusion: The effect of re-administration is limited, but it may be effective depending on the type of cases and the order of ICI administration. Further studies are required to verify its effectiveness." @default.
• W3201743025 created "2021-10-11" @default.
• W3201743025 creator A5024341045 @default.
• W3201743025 creator A5027591869 @default.
• W3201743025 creator A5045164790 @default.
• W3201743025 date "2021-01-01" @default.
• W3201743025 modified "2023-09-24" @default.
• W3201743025 title "For which lung cancer patients is re-administration of immune checkpoint inhibitors effective?" @default.
• W3201743025 cites W2108789863 @default.
• W3201743025 cites W2124427232 @default.
• W3201743025 cites W2167191456 @default.
• W3201743025 cites W2788431960 @default.
• W3201743025 cites W2799716227 @default.
• W3201743025 cites W2886634711 @default.
• W3201743025 cites W2904444972 @default.
• W3201743025 cites W2910245285 @default.
• W3201743025 cites W2946436670 @default.
• W3201743025 cites W2955392295 @default.
• W3201743025 cites W2965382925 @default.
• W3201743025 cites W2982865941 @default.
• W3201743025 cites W2994651425 @default.
• W3201743025 cites W2998298043 @default.
• W3201743025 cites W2998511916 @default.
• W3201743025 cites W3015860015 @default.
• W3201743025 cites W3016806376 @default.
• W3201743025 cites W3017125932 @default.
• W3201743025 cites W3028423564 @default.
• W3201743025 cites W3083986479 @default.
• W3201743025 doi "https://doi.org/10.2185/jrm.2021-025" @default.
• W3201743025 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8527621" @default.
• W3201743025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34707736" @default.
• W3201743025 hasPublicationYear "2021" @default.
• W3201743025 type Work @default.
• W3201743025 sameAs 3201743025 @default.
• W3201743025 citedByCount "1" @default.
• W3201743025 countsByYear W32017430252023 @default.
• W3201743025 crossrefType "journal-article" @default.
• W3201743025 hasAuthorship W3201743025A5024341045 @default.
• W3201743025 hasAuthorship W3201743025A5027591869 @default.
• W3201743025 hasAuthorship W3201743025A5045164790 @default.
• W3201743025 hasBestOaLocation W32017430251 @default.
• W3201743025 hasConcept C121608353 @default.
• W3201743025 hasConcept C126322002 @default.
• W3201743025 hasConcept C141071460 @default.
• W3201743025 hasConcept C143998085 @default.
• W3201743025 hasConcept C197934379 @default.
• W3201743025 hasConcept C2775949291 @default.
• W3201743025 hasConcept C2776256026 @default.
• W3201743025 hasConcept C2776694085 @default.
• W3201743025 hasConcept C2777701055 @default.
• W3201743025 hasConcept C2780030458 @default.
• W3201743025 hasConcept C2780057760 @default.
• W3201743025 hasConcept C71924100 @default.
• W3201743025 hasConcept C90924648 @default.
• W3201743025 hasConceptScore W3201743025C121608353 @default.
• W3201743025 hasConceptScore W3201743025C126322002 @default.
• W3201743025 hasConceptScore W3201743025C141071460 @default.
• W3201743025 hasConceptScore W3201743025C143998085 @default.
• W3201743025 hasConceptScore W3201743025C197934379 @default.
• W3201743025 hasConceptScore W3201743025C2775949291 @default.
• W3201743025 hasConceptScore W3201743025C2776256026 @default.
• W3201743025 hasConceptScore W3201743025C2776694085 @default.
• W3201743025 hasConceptScore W3201743025C2777701055 @default.
• W3201743025 hasConceptScore W3201743025C2780030458 @default.
• W3201743025 hasConceptScore W3201743025C2780057760 @default.
• W3201743025 hasConceptScore W3201743025C71924100 @default.
• W3201743025 hasConceptScore W3201743025C90924648 @default.
• W3201743025 hasLocation W32017430251 @default.
• W3201743025 hasLocation W32017430252 @default.
• W3201743025 hasLocation W32017430253 @default.
• W3201743025 hasLocation W32017430254 @default.
• W3201743025 hasOpenAccess W3201743025 @default.
• W3201743025 hasPrimaryLocation W32017430251 @default.
• W3201743025 hasRelatedWork W12336852 @default.
• W3201743025 hasRelatedWork W14333088 @default.
• W3201743025 hasRelatedWork W15508361 @default.
• W3201743025 hasRelatedWork W1671086 @default.
• W3201743025 hasRelatedWork W17183283 @default.
• W3201743025 hasRelatedWork W17235185 @default.
• W3201743025 hasRelatedWork W20305632 @default.
• W3201743025 hasRelatedWork W20396015 @default.
• W3201743025 hasRelatedWork W6095507 @default.
• W3201743025 hasRelatedWork W6195560 @default.
• W3201743025 isParatext "false" @default.
• W3201743025 isRetracted "false" @default.
• W3201743025 magId "3201743025" @default.
• W3201743025 workType "article" @default.